| Literature DB >> 26671995 |
Tatiana Erazo1, Mar Lorente2, Anna López-Plana3, Pau Muñoz-Guardiola4, Patricia Fernández-Nogueira3, José A García-Martínez5, Paloma Bragado3, Gemma Fuster3, María Salazar6, Jordi Espadaler5, Javier Hernández-Losa7, Jose Ramon Bayascas8, Marc Cortal5, Laura Vidal9, Pedro Gascón10, Mariana Gómez-Ferreria5, José Alfón5, Guillermo Velasco2, Carles Domènech5, Jose M Lizcano11.
1. Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
2. Department of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense, Madrid, Spain. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
3. Area of Molecular and Translational Oncology, IDIBAPS, Fundació Clínic, Universitat de Barcelona, Barcelona, Spain.
4. Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. Ability Pharmaceuticals, SL, Edifici Eureka, Campus UAB, Bellaterra, Barcelona, Catalonia, Spain.
5. Ability Pharmaceuticals, SL, Edifici Eureka, Campus UAB, Bellaterra, Barcelona, Catalonia, Spain.
6. Department of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense, Madrid, Spain.
7. Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
8. Institut de Neurociències and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.
9. Medical Oncology Department, Novel Therapeutics Unit, Hospital Clínic Barcelona. Barcelona, Catalonia, Spain.
10. Area of Molecular and Translational Oncology, IDIBAPS, Fundació Clínic, Universitat de Barcelona, Barcelona, Spain. Medical Oncology Department, Novel Therapeutics Unit, Hospital Clínic Barcelona. Barcelona, Catalonia, Spain.
11. Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. josemiguel.lizcano@uab.es.
Abstract
Entities:
Mesh:
Animals
Antineoplastic Agents/pharmacology
Cell Cycle Proteins/metabolism
Cell Death/drug effects
Cell Line
Cell Line, Tumor
Cell Proliferation/drug effects
Female
Humans
Mechanistic Target of Rapamycin Complex 1/metabolism
Mice
Mice, Nude
Proto-Oncogene Proteins c-akt/metabolism
Rats
Signal Transduction/drug effects
Up-Regulation/drug effects
Substances:
Antineoplastic Agents
Cell Cycle Proteins
Mechanistic Target of Rapamycin Complex 1
Proto-Oncogene Proteins c-akt
Year: 2015 PMID: 26671995 DOI: 10.1158/1078-0432.CCR-15-1808
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531